AS
Adam S Grossman sold $288K of ADMA stock
Adam S Grossman, President and CEO of Adma Biologics, Inc. (ADMA), sold 21,000 shares of ADMA stock worth $288K, per an SEC Form 4 filed Nov 17, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Nov 16, 2026, 1 day before it was made public.
ADMA has moved -2.2% since the trade date, from $13.47 to $13.17 (Nov 20, 2026 close).
- Traded
- Nov 16, 2026
- Disclosed
- Nov 17, 2026
- Filing delay
- 1 day
- Price since
- -2.2%
- Role
- President and CEO
- Source
- SEC Form 4